While many beauty companies are just beginning to evaluate PFAS (per-and polyfluorinated alkyl substances) risk, DSM-Firmenich has already delivered a scalable, commercially available, trifluoroacetic acid-free peptide portfolio.
For decades, PFAS (Per-and polyfluorinated alkyl substances) have powered innovation, delivering unrivalled durability, flawless performance, and the high efficiency materials that make modern beauty, fashion, and everyday life possible. But the very bonds that make PFAS built to withstand heat, chemicals, water, oil, and time itself, have brought the industry to a pivotal moment, and brands need to take the right next step so that pivot doesn't turn into a grinding halt.
Around the world, regulators are updating and expanding requirements. Definitions are shifting, and ingredients once considered essential are under unprecedented scrutiny. From the US FDA's ongoing evaluation under MoCRA (Modernization of Cosmetics Regulation Act of 2022) implementation to accelerating restrictions and phaseouts in multiple jurisdictions, PFAS have gone from quiet workhorses to headline makers, and every brand, formulator, and supplier is now being challenged to innovate faster than ever before.
This is the turning point. The industry must reimagine performance without compromise, delivering the same exceptional feel, stability, and reliability consumers expect, without the regulatory uncertainty that threatens long-term product viability. And that is exactly where the next chapter begins.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.